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A B S T R A C T
Although childhood adversity (CA) increases risk for subsequent mental illnesses, developmental mechanisms
underpinning this association remain unclear. The hypothalamic-pituitary-adrenal axis (HPAA) is one candidate
system potentially linking CA with psychopathology. However, determining developmental effects of CA on
HPAA output and differentiating these from effects of current illness has proven difficult. Different aspects of
HPAA output are governed by differentiable physiological mechanisms. Disaggregating HPAA output according
to its biological components (baseline tonic cortisol, background diurnal variation, phasic stress response) may
improve precision of associations with CA and/or psychopathology. In a novel proof-of-principle investigation
we test whether different predictors, CA (distal risk factor) and current depressive symptoms, show distinct
associations with dissociable HPAA components. A clinical group (aged 16–25) at high-risk for developing severe
psychopathology (n= 20) were compared to age and sex matched healthy controls (n= 21). Cortisol was
measured at waking (x4), following stress induction (x8), and during a time-environment-matched non-stress
condition. Using piecewise multilevel modeling, stress responses were disaggregated into increase and decrease,
while controlling for waking cortisol, background diurnal output and confounding variables. Elevated waking
cortisol was specifically associated with higher CA scores. Higher non-stress cortisol was specifically associated
with higher depressive scores. Following stress induction, depressive symptoms attenuated cortisol increase,
whilst CA attenuated cortisol decrease. The results support a differential HPAA dysregulation hypothesis where
physiologically dissociable components of HPAA output are differentially associated with distal (CA) or proximal
(depressive symptoms) predictors. This proof-of-principle study demonstrates that future cortisol analyses need
to disaggregate biologically independent mechanisms of HPAA output.
1. Introduction
Many mental disorders, including depressions and psychoses are
associated with exposure to childhood adversities (CA). One potential
pathophysiological pathway from CA to symptoms may involve long-
term alterations of the Hypothalamic-pituitary-adrenal axis (HPAA)
function leading to measurable differences in steroid outputs including
cortisol, adrenocortiocotropic hormone (ACTH) and corticotropin re-
leasing hormone (CRH) (Herbert, 2013; McEwen, 1998; Wilkinson and
Goodyer, 2011). Both human and rodent literature suggest that me-
chanisms modulating cortisol output are in part influenced by early
rearing factors during infant and childhood periods supporting pro-
gramming effects enduring through to adult life (Meaney et al., 2002;
Taylor et al., 2010; Weaver et al., 2004; Wilkinson and Goodyer, 2011).
Attempts to correlate variations in HPAA outputs to CA and psycho-
pathology have however yielded inconsistent findings within and across
psychiatric diagnostic categories (Ciufolini et al., 2014; Fogelman and
Canli, 2018; Young et al., 2000). This has made the formation of a
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robust developmentally sensitive theory of HPAA dysregulation for
subsequent mental disorders rather problematic. Alterations in HPAA
output may also be a consequence of dynamic endocrine effects that
change with disease state independent of any effects of CA - but this has
yet to be established.
The last few decades have continued to reveal increasingly complex
biological mechanisms underpinning HPAA function (Karatsoreos and
McEwen, 2011; McEwen, 2007; Sousa et al., 2008). In general terms,
HPAA output can be differentiated into tonic (background) and phasic
(reactive) components. Tonic cortisol release is also subject to diurnal
variation regulated by the central circadian clock, a function of the
hypothalamic suprachiasmatic nucleus (Czeisler et al., 1980; Dickmeis,
2009). In contrast, short-term phasic HPAA activation, such as seen
when confronted by novel, unexpected or uncontrollable stimuli
(Dickerson and Kemeny, 2004), is governed via various neural me-
chanisms involving the prefrontal cortex, limbic and brain stem regions
including activation in the Locus ceruleus, eventually resulting in cor-
tisol secretion. Phasic cortisol response to acute stress has multiple ef-
fects on subsequent neurophysiological adaptation (allostasis), in-
cluding the release of energy and shifts of cognitive network activation
(Danese and McEwen, 2012; Hermans et al., 2011).
In humans, with sleep being a period of relatively low differentia-
tion to environmental influences, waking cortisol is considered as
marker of baseline tonic output (Bartels et al., 2003; Kupper et al.,
2005). Support for elevated waking cortisol as trait-like biomarker
predicting depression has been demonstrated in adolescents (Owens
et al., 2014). While specific mediation through CA exposure was not
firmly established, heritable mechanisms partly accounted for these
findings (Bart et al., 2006; Schreiber et al., 2006).
Further, a number of studies have suggested that CA may be asso-
ciated with individual differences in stress related cortisol output
(Calhoun et al., 2014; MacMillan et al., 2009). Compromise of phasic
cortisol output (Wilkinson and Goodyer, 2011) may be a physiological
signature of ineffective adaptive coping (allostatic failure) to current
life stressors (Danese and McEwen, 2012; de Kloet et al., 2005). How-
ever, findings have been equivocal with CA predicting both increased
(Elzinga et al., 2003; Heim et al., 2002) and decreased (Calhoun et al.,
2014; Carpenter et al., 2007; Elzinga et al., 2008) cortisol output under
experimental stress in mentally ill participants.
Acute cortisol response to stress consists of two components: i) in-
itial increase, determined by a cascade of physiological mechanisms,
including CRH, ACTH and cortisol secretion, and ii) termination of the
response (cortisol decrease) which relies on efficient negative feedback
through glucocorticoid (GR) receptors. Both components (increase and
decrease) are sensitive to the impact of CA, for example, via interaction
of early rearing factors with vulnerability genes leading to long-term
alterations in the control of HPAA output (Mahon et al., 2013; Tyrka
et al., 2009; Zannas and Binder, 2014). For instance, CA has been as-
sociated with i) attenuated post-stress cortisol decrease via epigenetic
alterations of GR receptor sensitivity (Zannas and Binder, 2014), ii)
greater post-stress cortisol increase due to epigenetic influences on CRH
activation (Tyrka et al., 2009). These effects are considered as in-
dependent of each other and illustrate two distinct mechanisms ac-
counting for altered post-stress cortisol levels in vulnerable individuals.
In summary, components of cortisol output are underpinned by
differentiable control mechanisms: background diurnal output sub-
served by the suprachiasmatic nucleus and the circadian clock; reactive
increase in cortisol, subserved by a neurally sensitive cascade system
via CRH activation; baseline tonic cortisol levels and post-stress cortisol
restitution controlled via negative feedback at GR receptors. To date the
impact of either CA and/or current illness on these components has not
been systematically differentiated, thus possibly accounting for incon-
sistent findings.
We conjecture that to better understand the impact of CA on HPAA
function in patients with mental illnesses requires measuring the fol-
lowing HPAA outputs in a single experimental design: tonic waking
cortisol (baseline output), diurnal background cortisol (non-stress), and
both components of phasic cortisol (increase and decrease) in time-
environment-matched non-stress and stress conditions. To undertake
this strategy a multivariate modeling procedure is required that allows
for piecewise disaggregation of cortisol components when testing for
specific associations between different cortisol outputs and CA and/or
current symptoms.
Based on these considerations we speculate that a history of CA
would be associated with alterations in HPAA components where pro-
gramming effects are predicted. In contrast, we consider that current
symptoms are more likely associated with an overall general elevation
in daytime cortisol levels. We therefore test the following hypotheses:
1. Greater CA will be associated with elevated waking cortisol levels
and attenuated post-stress cortisol decrease due to programing ef-
fects impairing negative feedback mechanisms (Zannas and Binder,
2014). Higher waking cortisol likely correlates with impaired post-
stress physiological recovery.
2. Higher symptom scores will be associated with elevated cortisol
levels across the non-stress condition due to illness related effects
such as distress (Dienes et al., 2013).
3. CA may predict greater post-stress cortisol increase in a subgroup,
due to programing effects on CRH release (Tyrka et al., 2009).
In the present study we used a well-validated experimental stress
induction paradigm (Kirschbaum et al., 1993) measuring post-stress
phasic cortisol outputs in a late adolescent/young adult (aged 16–25)
clinical group at high risk of developing severe psychopathology versus
age and sex matched controls with no lifetime history of mental illness.
As cortisol release shows high diurnal variability with different rates of
decline throughout the day and also responds to a wide range of in-
ternal or external triggers, we measured diurnal variation (without
induced stress) under equivalent environmental conditions at time-
matched diurnal times. In addition, we established baseline tonic cor-
tisol levels at waking by measuring morning waking cortisol over four
days prior to experimental procedures. Current symptoms and CA were
ascertained via questionnaires. We applied updated analytical ap-
proaches (see below) to partition out the contribution of baseline cor-
tisol and diurnal variation, as well as taking account of intra-individual
and inter-individual variations of sampling, and timing of peak cortisol
concentrations. This allows assessing distinct associations of different
cortisol outputs under waking, non-stress and stressful conditions with
CA and current symptoms in patients.
2. Materials and methods
We conducted a case-control experiment comparing a Clinical
Group (CG) with community ascertained Healthy Controls (HC). Three
HPAA output components were measured: 1) morning waking cortisol,
2) cortisol following stress induction, 3) daytime (diurnal) cortisol in a
non-stress condition. The latter two were measured on separate days at
equivalent time-points (details below). The study was approved by the
NRES East of England committee and was performed in accordance
with relevant guidance and regulations.
2.1. Participants
CG (n= 20) were recruited from a specialist mental health service
for young people aged 16–35 years, presenting for the first time with
psychotic symptoms, meeting criteria for at-risk mental state for psy-
chosis according to the Comprehensive Assessment of At Risk Mental
States (CAARMS) (Yung et al., 2003), but not for a full psychotic epi-
sode (Supplementary Information: Full criteria for At-risk mental
states). HC (n=21) were recruited from a panel of volunteers with no
lifetime history of mental illness. All participants took part in this study
as part of a project investigating the relationship between CA, changes
V.B. Dobler, et al. Neurobiology of Stress 10 (2019) 100153
2
in HPAA output, alterations in cognitive performance and symptoms in
young people at-risk of developing severe psychopathology. Herein we
report on the characterization of the HPAA profile of the participants.
Psychotic experiences (such as hallucinations) have a relatively high
prevalence in adolescent/young adult populations (Varghese et al.,
2011; Wigman et al., 2012) (Kelleher et al., 2012a), but have been
found to represent an unspecific symptomatic marker of increased risk
for developing severe psychopathology with high levels of co-morbidity
across the spectrum of anxiety, depression and psychotic disorders
(Kelleher et al., 2012b). Psychotic experiences are also strongly asso-
ciated with a history of CA (Caspi, 2010; Kelleher et al., 2013, 2008).
Our clinical group therefore represented individuals with a high-risk for
developing severe psychopathology and a high probability of having
experienced CA (Varghese et al., 2011; Wigman et al., 2012). Particu-
larily in young populations, symptoms fluctuate and tend to dynami-
cally develop across various diagnostic categories over time (Caspi
et al., 2014; Cramer et al., 2010). Equally, some mood or anxiety re-
lated symptoms may be experienced in healthy populations without
reaching pathological significance or impairment. Recent research
suggests that, especially in young populations with emerging mental
illness, a dimensional approach may be better suited to adequately
describe current psychopathology (St Clair et al., 2017; Stochl et al.,
2015). In the present study, current symptoms/clinical status were
therefore characterized in four ways; i) determining at-risk status
(CAARMS), ii) determining the current formal categorical DSM IV di-
agnosis via a clinician-led MINI current mental state diagnostic inter-
view (Sheehan et al., 1998), iii) determining symptoms dimensionally
in relation to depression, delusional thought content, and anxiety pro-
neness on continuous scales and, iii) determining level of functioning/
impairment. Exclusion criteria included habitual smoking, current use
of antipsychotic medication, steroid medication or contraceptive pill
(Supplementary Information: Full recruitment procedure, inclusion/
exclusion criteria). General cognitive functioning (IQ) was established
using the Catell culture fair test of intelligence (Cattell, 1940).
2.2. Procedures
Participants were telephone screened for eligibility and, if they met
criteria, invited for an initial interview and written informed consent
prior to participation in the study. Participants were given instructions
for at-home saliva collection and asked to bring the samples to the
testing sessions. All testing followed a fixed protocol and timing
whereby all procedures were conducted at the same times of day. Stress
and non-stress days were counterbalanced according to a pre-set ma-
trix. Dates were set a minimum of 2 weeks apart. Prior to each testing
session participants were screened for compliance with the inclusion
criteria. Stress induction was followed by end-of-session debriefing.
2.3. Cortisol samples
2.3.1. Waking cortisol
Patients were instructed to collect saliva upon waking on two days
prior to coming to each testing session (4 samples in total). A kit with
Salivettes (SalimetriCG®) and full written instructions were provided
(Supplementary Information: Written instructions).
2.3.2. Test days salivary cortisol collection
Samples were collected at set time points between 12.45 and 14.30
in the laboratory on each testing day (TSST: eight sessions; non-stress:
six sessions). The stress condition consisted of a well validated stress
induction procedure (Trier Social Stress Task (TSST) (Kirschbaum et al.,
1993)). The TSST is a standardized socially evaluative stress induction,
which includes elements of anticipation (participants are introduced to
a panel of judges and asked to prepare a presentation for a job inter-
view), public speaking (presentation in front of panel) and mental ar-
ithmetic (in front of panel). Stress induction elicited “TSST cortisol”.
The non-stress condition assessed background diurnal daytime varia-
tion at the time of testing, under controlled laboratory conditions
(“non-stress cortisol”). To control for mental and physical activity,
participants were asked to follow instructions of a progressive muscle
relaxation tape of equal duration to the TSST. Baseline cortisol was
collected prior to either intervention. All other samples were collected
post-intervention (stress/non-stress) at as close as possible matching
time points for both conditions. On both days participants performed
the same set of computer tasks and questionnaires post-intervention
whilst collecting salivary samples. (Supplementary Information: Fig.
S1).
The saliva samples were stored in a freezer upon receipt and ana-
lyzed at the local Core Biochemical Assay Laboratory (CBAL)
(Cambridge University Hospitals NHS Foundation Trust), using
SalimetriCG® Salivary Cortisol Enzyme Immunoassay Kit for duplicate
cortisol analysis.
All cortisol data were logged in order to minimize the impact of
outliers (Hruschka et al., 2005).
2.4. Symptom scales and measures for CA
Current mood symptoms in the whole sample were established with
the self-reported Beck Depression Inventory BDI (Beck et al., 1996)
immediately prior to the stress and non-stress sessions, with the mean
score being used in analyses. The Peters Delusion Inventory (PDI)
(Peters et al., 1999) was obtained as a measure of abnormal beliefs
(appropriate for clinical and non-clinical populations) and the State-
Trait-Anxiety Inventory (STAI-T) (Spielberger, 2010) was used to as-
certain levels of anxiety-proneness. Both were obtained once at the
beginning of the study, as was the level of everyday functioning using
the Global Assessment of Functioning (GAF, DSM-IV). CA was assessed
using the self-reported Childhood Trauma Questionnaire (CTQ)
(Bernstein et al., 2003). Of the symptom measures, BDI has the greatest
established clinical validity (Storch et al., 2004). Given that it also was
assessed immediately before each testing session, we chose the BDI as
the most proximal index of symptoms when examining associations
between current symptoms and HPAA components.
2.5. Data analysis
The aims of the data analysis were threefold: first to establish
waking cortisol characteristics; second to reveal characteristics of the
diurnal cortisol in the non-stress condition; third to characterize the
effects of stress on increase and decrease of cortisol levels taking both
waking cortisol levels and non-stress (diurnal) levels into account.
Multi-level mixed-effects linear regression using maximum like-
lihood was performed to interrogate the panel cortisol data. Prior stu-
dies assessing cortisol reactivity have utilized this approach as it ac-
counts for intra-individual variation of baseline (Hruschka et al., 2005),
missing data, unequally spaced data points (Willett et al., 1998), and
non–independence of repeated measures data (Hruschka et al., 2005). A
piecewise approach has previously been taken to separate cortisol re-
activity and recovery post-stress, also with a similar sample size to the
present study (Hollocks et al., 2014).
However, here we also account for both waking cortisol and non-
stress cortisol, and use individual peak cortisol levels instead of group
means.
Primary outcomes were waking cortisol, TSST (stress)- and non-
stress cortisol. The effects of our three key predictors, clinical group
(primary predictor), BDI (proximal predictor), and CTQ (distal pre-
dictor), were assessed in separate models due to high correlations
among the predictors. In order to effectively test the association of BDI
and CTQ with cortisol, we pooled HC and CG to allow for a more
complete range of BDI and CTQ scores, in models where these were
predictors. In each model, IQ, age, test day order, gender, and waking
cortisol (for TSST and non-stress cortisol outcomes) were assessed as
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fixed-effect confounders; those which were related to both the outcome
(p < 0.1) and predictor (p〈0.1 or r/ρ〉=0.1) were included in each
model. Thus, not all confounders will be the same in each model.
Repeated measurements were nested within individuals (a random-ef-
fect). In models predicting waking cortisol, main fixed-effects of pre-
dictors were assessed, along with fixed-effects of day and time of
waking, and random-effects of time of waking, due to repeated as-
sessments across four days. For TSST and non-stress cortisol outcomes,
time of measurement was modeled as a fixed (linear and quadratic) and
random-effect (linear only), as participants' cortisol measurements were
not always equally spaced in time (Supplementary Information: Table
S1). Key predictors (HC/CG, BDI, CTQ) were included in separate
models, each as a fixed interaction with time to assess the influence of
these factors on cortisol's change over time (i.e.: slope). Putative con-
founders which correlated with these predictors were also in-
dependently interacted with time on cortisol; those interactions which
were p < 0.01 were included in each relevant model. Despite a small
sample size, we were able to include confounders in the models, as all
our models contained well over two subjects per variable, the re-
quirement necessary in regression models for adequate estimation of
regression coefficients, standard errors, and confidence intervals
(Austin and Steyerberg, 2015).
TSST baseline, peak, and end of the cortisol reaction: The value used
for TSST baseline cortisol response was obtained immediately prior to
the start of the TSST. This was an average of 20min (SD=4) after
participants arrived in the testing room, allowing relaxation after the
physical exertion of getting to the appointment. As the timing of peak
cortisol response varies between individuals (Kirschbaum et al., 1993),
we assessed which of three theoretically plausible peaks reflected each
participant's maximum cortisol output. These peaks were set to be the
highest TSST cortisol value at a mean of 23min (SD=1), 29min
(SD=2), or 36min (SD=2) after the start of the task (74). The end of
the TSST cortisol reaction was set at a mean of 58min (SD=5) after
the start of the task, a mean of 22 (SD=2) to 34 (SD=5) minutes after
the peak. To separately model cortisol reactivity increase and decrease,
the dataset was split into two at the TSST peak cortisol level (varying by
individual), allowing for piecewise analysis of these phases.
TSST Extreme responders: Given prior reports suggesting that CA is
related to overall decreased post-stress cortisol but increased cortisol
release in a subgroup (Tyrka et al., 2009), we explored the sample for
potential extreme responders prior to further analysis. TSST cortisol
slope from start to peak was calculated and inspected for outliers.
TSST minus non-stress cortisol: In order to consider TSST cortisol
reactivity whilst controlling for individual variation in cortisol in the
same environment under non-stress condition (“non-stress cortisol”),
we subtracted logged non-stress cortisol from logged TSST cortisol.
Prior to this, we accounted for individual variation in the timing of
sample collection by imputing the non-stress data to the exact time
points of the TSST data (Supplementary Information: Fig. S2). Piece-
wise multilevel modeling described above were repeated with “TSST
minus non-stress cortisol” as the outcome.
3. Results
3.1. Participant characteristics
CG (n= 20; 14 male) had a mean age of 20.8 years (SD=2.75) and
HC (n= 21; 11 males) had a mean age of 20.2 (SD=3.25). While all
patients were referred due to psychotic symptoms, 75% (n= 15) met
criteria for a diagnosis based on the MINI diagnositic interview
(Sheehan et al., 1998). Most common primary diagnoses were depres-
sive diagnoses (n=8 (40%)), followed by anxiety spectrum diagnoses
(n=7 (35%)). As expected in this age group, 60% (n=12) also had at
least one secondary diagnosis (7 depressive, 5 anxiety); three met cri-
teria for a third diagnosis. Despite being identified as at-risk-mental-
state, 5 participants did not meet full criteria for a diagnosis according
to the MINI, although they exhibited a sufficient range of symptoms
and/or impairment in functioning to justify inclusion in the clinical
group (Fig. 1; Supplementary Information: Table S2). Eight patients
took psychotropic medication, usually SSRIs (Supplementary Informa-
tion: Table S2). As expected, the CG versus HC showed significantly
higher symptoms, CA, and impairment (Fig. 1A and Table 1). CG/HC
was collinear with BDI and CTQ (rho 0.87 and 0.84 respectively). There
was no significant between-group difference in IQ (Table 1). Across
both groups, in the full dataset, CTQ scores were strongly correlated
with BDI scores (r= 0.63), and BDI was colinear with PDI and STAI
(r= 0.81 and r= 0.85 respectively). Among those in the clinical group,
there were increased levels of trait anxiety (STAI-T), psychotic believes
(PDI), and depressive symptoms (BDI) irrespective of diagnosis. Fur-
ther, all diagnostic groups showed a mean score of depressive symp-
toms (BDI) above clinical threshold (mild depression). Two HC reported
below threshold unusual perceptual experiences/unusual thought con-
tent on the CAARMS.3 There was one HC who exceeded the clinical cut-
off for depression on the BDI (20), one high outlier on the PDI, and 10
HC with self-reported increased levels (> 35) of anxiety proness.
However these were without associated functional impairment, there-
fore not meeting criteria for a clinical diagnosis. Further, there were 5
HC who had experienced moderate or severe CA based on CTQ, and 7
CG who had experienced none or low CA, reflecting a range of ex-
periences across the samples. In summary: although some mild symp-
toms were reported in our HC, the CG and HC differed significantly on
all symptom levels, CA and impairment.
3.2. TSST exclusions
One HC was excluded from all TSST analyses due to consistently
high and improbable cortisol levels throughout the TSST (> 3 dl,
(Salimetrics ® Assay range: 0.012. −3.000 μg/dl, with 3 dl representing
the ceiling of the test). However, this participant's data was retained in
any tonic (morning and non-stress) cortisol analysis as these levels were
well within range of other HCs. Three CG had extreme responses on the
TSST, with mean slope 6.5 times greater than all the remaining parti-
cipants (M=0.88, SD=0.28; Supplementary Information: Fig. S3),
including the HC, and therefore would be inappropriate to include. As
the extreme responders were clearly too few to analyze separately, they
were excluded from any TSST analyses, bringing the sample to 17 CG
and 20 HC. (These individuals' non-stress cortisol data was normal and
therefore was used in non-stress analyses). Additionally, one in-
dividual's cortisol did not increase during the TSST; these data were
used for cortisol increase, but cortisol decrease was not calculated due
to no prior increase.
3.3. Waking cortisol
Waking cortisol was not significantly different between the four
sampling days, nor did time of waking influence cortisol as a fixed-
effect. However, inclusion of time of waking as a random-effect im-
proved model fit (Akaike information criterion decreased) and thus was
included in all models with waking cortisol as outcome. One HC par-
ticipant was missing waking cortisol data. Only CTQ was positively
associated with waking cortisol; no association was found with HC/CG
or depressive symptoms (Table 2). Waking cortisol was also assessed as
a predictor of non-stress and “TSST minus non-stress cortisol””, with
confounds included as described in methods. Waking cortisol did not
influence non-stress cortisol decline (i.e.: no interaction with time:
linear p= 0.59, quadratic p=0.49) or non-stress cortisol levels across
the whole testing period (p= 0.79). Additionally, waking cortisol did
not influence slope increase or decrease in the “TSST minus non-stress”
3 Hypnogogic-hypnopmpic experiences/occasional feeling that others look or
talk about the subject.
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condition, but it did yield a positive influence on overall cortisol values
from TSST peak to finish (Fig. 2).
3.4. Cortisol under non-stress condition
There was a significant diurnal decline of cortisol over time (line-
arly: Coef=−0.26×10−2 (−0.49× 10−2 to −0.02×10−2),
p= 0.033; quadratically: Coef=−6.25× 10−5 (−11.90×10−5 to
−0.60×10−5), p= 0.030). None of the predictors influenced this
slope. CG versus HC and BDI scores were positively associated with
higher overall cortisol across all time points (Fig. 3).
3.5. Cortisol and TSST condition
Piecewise analysis of “TSST minus non-stress cortisol” revealed
linear but not quadratic effects of time in the increase (baseline to peak)
and decrease (peak to end) phase (Supplemental Information: Table S3)
Therefore only interactions with time (not time2) were assessed. An
attenuated cortisol increase was noted in CG compared with HC, which
was a trend level for cortisol decrease (Fig. 4A). Higher BDI scores at-
tenuated cortisol increase (Fig. 4C), and higher CTQ scores attenuated
cortisol decrease (Fig. 4B). Findings with “TSST minus non-stress cor-
tisol” differed from TSST uncontrolled for diurnal cortisol. TSST cortisol
uncontrolled by non-stress cortisol showed CG, CTQ, and BDI had no
effect on cortisol increase but all attenuated cortisol decrease (Sup-
plementary Information: Table S4).
Fig. 1. Symptom characteristics (A) and impairment (B) within diagnostic categories in Clinical Group (CG) and Healthy Controls (HC). A: Cumulative scores in self-
rated questionnaires on delusional thought content (PDI), anxiety proness (STAI-T) and depression (mean BDI) in HC and CG (N=no diagnosis, A= anxiety
spectrum, D=depression). While some sypmptoms were present in the HC with no lifetime history of mental illness, in the CG all symptom scales were significantly
elevated. B: In comparison to the HC the CG was functionally impared according to the GAF.
Table 1
Participant characteristics.
Combined mean (SD) n HC mean (SD) n CG mean (SD) n t-test p
BDIa 14.43 (13.15) 41 5.13 (5.21) 21 24.20 (11.81) 20 −6.75 < 0.0001
PDI 8.78 (9.20) 40 3.38 (5.19) 21 14.74 (9.05) 19 −4.93 < 0.0001
CTQ 41.88 (17.98) 40 31.05 (4.41) 20 52.70 (19.93) 20 −4.74 < 0.0001
STAI-T 47.71 (14.28) 41 37.52 (8.85) 21 58.40 (10.58) 20 −6.87 < 0.0001
GAF 65.55 (22.40) 33 86.53 (3.91) 17 43.25 (4.97) 16 27.89 < 0.0001
IQ 117.29 (17.80) 41 121.33 (18.11) 21 113.05 (16.87) 20 1.51 0.14
HC=healthy controls; CG=clinical group; BDI=Beck Depression Inventory; PDI=Peters Delusion Inventory; STAI-T=State-Trait-Anxiety Inventory (Trait Anxiety);
GAF=Global Assessment of Functioning; IQ=General cognitive functioning.
a Mean of scores taken prior to each testing day.
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In summary, a differential pattern of predictors of the differential
aspects of cortisol output emerges:
i) Higher CTQ scores were associated with elevated morning cortisol
levels.
ii) BDI scores were associated with overall elevated cortisol in the non-
stress condition.
iii) In the stress condition (controlling for the non-stress cortisol levels)
current depressive symptoms were associated with attenuated cor-
tisol increase. Conversely, higher CTQ scores were associated with
attenuated cortisol decrease.
4. Discussion
While both HPAA and CA have been related to various types of
psychopathology, correlations within and across psychiatric diagnostic
categories have been inconsistent (Ciufolini et al., 2014; Fogelman and
Canli, 2018; Young et al., 2000). Recently it has been suggested that
new approaches may be nessecary to tackle heterogeneity in findings of
HPAA outputs in relation to CA and psychopatology (Fogelman and
Canli, 2018). Within the present study, we set out to systematically
disaggregate the associations between current depressive symptoms
and self-reported CA with components of HPAA output in participants
at-risk to developing severe psychopathology (CG) and HC with no
lifetime history of mental illness. We chose this strategy because of
potentially distinct underlying latent mechanisms governing waking
cortisol levels, diurnal decline and components of phasic cortisol re-
sponse (increase and decrease) that may be differentially susceptible to
exposure to CA and/or current symptoms. We hypothesized that CA and
current illness would show different associations with distinct compo-
nents of HPAA output. In order to test this, we needed to disaggregate
the phasic response to stress into its physiological components of in-
crease and subsequent decrease, distinguish high from low responders,
control for baseline tonic output at waking and partition out the al-
terations in non-stress diurnal cortisol output at the same time of day.
Consistent with our first hypothesis, we revealed that elevated tonic
waking cortisol was associated specifically with higher CTQ scores re-
gardless of group (case-control). Furthermore, higher CTQ scores were
also specifically associated with attenuated phasic post-stress cortisol
decrease. Elevated waking cortisol correlated with higher post-peak
cortisol after stress induction.
Given the small sample size and lack of genetic data to control for
genetic effects on morning waking cortisol levels or post-stress de-
crease, we cannot make definite claims regarding the precise me-
chanism underpinning these effects. However, CA related, epigeneti-
cally determined downregulation in GR sensitivity, with successive
impairments in negative feedback mechanisms may provide one pos-
sible explanation for the association between CA, elevated waking
cortisol as marker of increased baseline tonic output, and attenuated
post-stress recovery, independent of symptom related effects. Our
findings are theoretically consistent with developmental programming
effects following CA exposure, which only affect distinct components in
HPAA output in vulnerable populations, but are potentially related to
long term risk of successive severe psychopathology. If confirmed in
future studies this provides a potential explanatory framework for
morning waking cortisol acting as a biomarker amongst the adolescent
‘at risk’ population for major depression (Owens et al., 2014), that is
explained by both heritable mechanisms and CA.
In contrast, cortisol levels measured during the non-stress condition
were positively associated only with symptom scores of current de-
pression, suggesting that, the more severe the illness profile the greater
Table 2
Waking cortisol.
Distal and proximal influences on waking cortisola
Effect Nb Coef 95% CI p
Main Effects
Day 151 (39) −4.87× 10−2 −13.42× 10−2 to 3.68× 10−2 0.26
Time of waking 151 (39) −0.07× 10−2 −0.29× 10−2 to 0.15× 10−2 0.52
HC/CG (1=CG) 143 (37) 6.37×10−2 −26.02× 10−2 to 38.75×10−2 0.70
CTQ 147 (38) 0.92×10−2 0.36× 10−2 to 1.49×10−2 0.001
BDI 151 (39) 0.42×10−2 −1.24× 10−2 to 2.08× 10−2 0.62
Waking cortisol levels were not influenced by HC/CG, but they were associated with increased CTQ scores.
a Multilevel model across 4 days. Only the CTQ model required adjustment for confounding (gender was included). All models include random effects of time of
waking (missing in 1 individual), but findings remain when this random effect is not included.
b Bracketed number refers to the number of cases. Waking cortisol was missing from one HC participant, and time of waking was missing for another. CTQ was
missing from an additional participant. HC/CG analyses excluded two participants who were outliers on BDI or PDI.
Fig. 2. Predictive marginsb of waking cortisol on “TSST minus non-stress cor-
tisol” increase and decrease (TSST=Trier Social Stress Test), adjusted by
confounds. Piecewise analysis of cases and controls together revealed that
waking cortisol levels did not influence “TSST minus non-stress cortisol” in-
crease (Coef= 0.32×10−2 (95% CI: 0.73×10−2, 1.36× 10−2), p=0.55;
confound: gender x time) or decrease (Coef= 0.49×10−2 (−0.54× 10−2,
1.53×10−2), p= 0.35; confounds: age x time, gender). However, waking
cortisol had a positive influence on overall “TSST minus non-stress cortisol”
levels, non-significant from TSST start to peak (Coef= 0.21 (−0.02, 0.43),
p= 0.074; confound: gender), but significant from TSST peak to finish
(Coef= 0.34 (0.03, 0.65), p=0.031; confound: gender). Sample size: Four
TSST ouliers were excluded (see method and results). Waking cortisol was
missing from one participant. The decline phase additionally excluded one
participant who exhibited no cortisol increase from the TSST. All TSST slope
increase and decrease models have 3 to 5 timepoints per person, which varies
depending on when each individual peak occurred. This resulted in n=132 (36
participants) for analyses of cortisol increase, and n= 151 (35 participants) for
cortisol decrease.
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the likelihood of an overall elevated diurnal cortisol output. The results
are consistent with our second hypothesis and support an independent
effect of current symptoms on parameters of HPAA output, irrespective
of CA. These latter results resonate with studies noting that a proportion
of currently depressed patients show a reversible loss of day and
nighttime diurnal rhythm in their HPAA function, and this may be more
likely in the most severely ill patients (Binder et al., 2004). To our
knowledge, this is the first study specifically assessing diurnal variation
at time-matched intervals to the stress related phasic response. The
above findings strongly support our methodological approach of con-
trolling for non-stress characteristics of the HPAA output in order to
systematically disaggregate the impacts of CA and current symptoms
respectively when investigating HPAA phasic response to stress in pa-
tients.
In addition, we noted that greater depressive symptoms correlated
with attenuated post-stress phasic cortisol increase. We hypothesized
that perhaps during illness, already increased daytime diurnal HPAA
output may limit the physiological reserve for adaptive (allostatic) post-
stress cortisol increase.
Previous clinical studies have suggested both an increased and at-
tenuated phasic cortisol response to acute stress in populations with CA
and mental illness (Calhoun et al., 2014; Carpenter et al., 2007; Elzinga
et al., 2008, 2003; Heim et al., 2002). In line with our third hypothesis
we identified a small subgroup of clinical participants showing extreme
cortisol reactivity. The theoretical approach to analyses in this study is
guided by understanding of the biological underpinnings of cortisol
realease to date. On this basis, excluding these from the rest of the
sample was justified: based on previous literature, they likely represent
a further physiologically distinct clinical subgroup related to gene-by-
environment mechanisms affecting CRH control (Bradley et al., 2008;
Tyrka et al., 2009). Future studies with larger sample sizes might be
able to further explore CA/illness related associations in such sub-
groups.
To date findings of HPAA abnormalities have been inconsistent
within or across diagnostic categories. Co-morbidity in DSM IV diag-
noses was common in our sample. This was expected as the CG was
recruited based on psychotic symptoms, as marker for high-risk of
emerging severe psychopathology (Kelleher et al., 2012b) and related
to high levels of co-morbidity in young populations. Therefore, and in
recognition of increasing calls for dimensional definitions of mental
health in research (Caspi et al., 2014; Krueger et al., 1998) we chose a
dimensional approach to characterizing current psychopathology across
several symptom domains of depression, anxiety and abnormal beliefs.
This also allowed pooling data across samples for some of the analyses.
Despite the categorical diagnostic hereogeneity within the CG, higher
levels of symptoms in all domains were seen in CG versus HC, irre-
spective of CG diagnosis. The symptom profile of our group resonates
with the increasing recognition that diagnostic categories represent less
distinct pathologies than previously thought, but overlapping symptom
clusters (Cramer et al., 2010), with a potentially common latent factor
Fig. 3. Influence of predictors on non-stress cortisol, adjusted by confounds. Predictors did not influence non-stress cortisol slope (all interactions with time and
time2, p≥ 0.36). Therefore main effects of predictors are presented, adjusted for confounding, and including the quadratic effect of time. 95% Confidence intervals
are from the standard error of prediction. Continuous predictors were divided into quartiles to depict their influence on non-stress cortisol. A) The clinical group (CG)
exhibited higher levels of non-stress cortisol than the healthy controls (HC) throughout the testing period (Coef= 0.47, (0.19, 0.75), p= 0.001; confound: gender;
n= 236 [41 participants x 6 timepoints.]). B) Across the whole sample, CTQ scores did not influence non-stress cortisol levels (Coef= 0.34× 10−2 (−0.45×10−2,
1.13×10−2), p=0.40); confounds: gender, IQ; n=240 [40 participants x 6 timepoints. One participant was missing CTQ]). C) Across the whole sample, those with
higher BDI scores had higher levels of non-stress cortisol throughout the testing period (Coef= 1.11×10−2 (0.33×10−2, 1.89×10−2), p= 0.005; confounds: IQ,
test day order; n= 246 [41 participants x 6 timepoints]).
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underpinning mood, anxiety and psychotic disorders (Stochl et al.,
2015). CA and HPAA abnormalities are associated with many mental
illnesses. CA related programming effects on physiological changes may
be present irrespective of the dynamic effects of current symptom status
(Faravelli et al., 2010), and possibly represent a latent mechanism
common to these symptom clusters.
Stress induction in clinical populations is notoriously difficult to
conduct due to primary and secondary contraindications of inflicting
stress upon an unwell population. Therefore most current data rely on
sub-clinical population studies or small numbers in clinical groups
(Heim et al., 2002; Hollocks et al., 2014; Young et al., 2000). Clearly,
conclusions of this study are limited by its small sample size and re-
plication is needed in larger sample sizes using similar methodology.
For example, larger sample sizes would allow for assessment of cortisol
profiles separately by clinical status and/or gender. However, to our
knowledge this is the first study employing piecewise multilevel mod-
eling to fully disaggregate different physiological components of the
phasic HPAA response in mentally ill patients. By using this approach,
we maximize the power of a small data set over 2 experimental days
(stress and non-stress). We also provide a proof-of-principle for the
importance of this statistical disaggregation by revealing putatively
different effects on tonic, diurnal and phasic cortisol outputs and fur-
ther demonstrate the importance of controlling for the non-stress
diurnal levels in such populations.
Theoretically, distinguishing physiological subgroups is of value in
preparation for delineating developmental pathways resulting from the
impact of CA. For example, CA has been theorized to evoke specific
changes in HPAA function, and putative subsequent downstream de-
velopmental events (Cicchetti, 2010), with specific influence on neu-
rocognitive processes (Diamond et al., 2007; Lupien et al., 2007). In-
deed, high waking cortisol levels have been associated with
overgeneralized autobiographic memories (Owens et al., 2014). Future
developmental theories of HPAA dysregulation in the pathogenesis of
mental disorders could benefit from accounting for the heterogeneity of
cortisol profiles (Fogelman and Canli, 2018; Hagan et al., 2015).
5. Conclusions
Herein we present a novel approach to cortisol analysis which sys-
tematically disaggregates components of HPAA output. Such analysis
Fig. 4. Influence of predictors on “TSST minus non-stress cortisol” increase and decrease, adjusted by confounds. Predictive marginsb are used in B and C to show the
influence of a continuous predictor on cortisol slope. A) The clinical group (CG) exhibited an attenuated increase (Coef=−10.57×10−3 (95% CI: 19.92×10−3,
−1.21× 10−3), p= 0.027) and trend level decrease (Coef= 9.56× 10−3 (1.27× 10−3, 20.38× 10−3), p= 0.084) in cortisol compared with healthy controls
(HC), as shown by significant interactions of HC/CG with time. B) Across the whole sample, CTQ scores did not influence cortisol increase (p= 0.51; full statistics
presented in Table S3) but higher CTQ scores attenuated cortisol decrease (Coef= 0.31× 10−3 (0.03× 10−3, 0.59× 10−3), p=0.028). C) In the whole sample,
higher BDI scores attenuated cortisol increase (Coef=−0.41× 10−3 (−0.76× 10−3, −0.05× 10−3), p= 0.025) but not decrease (p= 0.15). (See Table S3 for
confounds and sample size; TSST=Trier Social Stress Test). bFor depicting effects of continuous predictors (CTQ and BDI) on “TSST minus non-stress cortisol”,
predictive margins were computed from each model at the mean of the predictor, and ± 1SD from the mean. (Predictive margins are computed probabilies of the
outcome at specified values for the independent variable in the model.
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has allowed us to distinguish effects of CA and current depressive
symptoms on cortisol levels in young people at high-risk for developing
severe mental illness. Our findings provide preliminary novel evidence
for a differential HPAA axis dysregulation hypothesis regarding the
impact of CA and current depressive symptoms on specific components
of HPAA output. We suggest that the elevated waking cortisol and at-
tenuated cortisol decrease post-stress in this population likely reflects
negative glucocorticoid feedback as a result of programing effects via
an interaction of CA with vulnerability genes, rather than being directly
symptom related. Impaired negative GR feedback has been associated
with various disorders, including depression and psychcosis (Zannas
and Binder, 2014). Consistent with the clinical presentation of our
sample (multiple, mixed symptoms, high prevalence of CA) our sample
might represent a subgroup of youth at-risk of a more severe course of
illness, greater treatment resistance, and lifelong risk of for recurrent
illness. Future studies will need to establish the programing effect of CA
vesus later life adversity. During illness, elevated daytime cortisol
output may deplete cortisol reserves and further compromise the ca-
pacity for adaptive physiological responsiveness to current stress, and
thus contribute to maintenance of symptom levels. These conclusions
are clearly tentative due to several limitations of the study, including
the sample size limiting subgroup-analyses. Future studies will need to
replicate and extend these findings with larger sample sizes. However,
the proposed methodology in this proof-of-principle study provides a
tool for the differentiation of distinct, biologically plausible subgroups.
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